Superworth

Bristol-Myers Squibb EPS BMY

Diluted earnings per share by quarter and over the last twelve months, from 2008.

Last 12 months, to Sep 30, 2026
$4.51
Latest quarter, Q3 FY26
$1.05
−3% on a year earlier
Fiscal year 2025
$3.45

Bristol-Myers Squibb's earnings per share was $4.51 over the twelve months to Sep 30, 2026, up 52% on a year earlier.

In its latest quarter, Q3 FY26, it was $1.05, down 3% on the same quarter a year before.

Earnings per share over time

Open the interactive chart, with overlays and comparisons

Fiscal year by fiscal year

Fiscal yearEPSChange
FY2025$3.45n/a
FY2024−$4.42−215%
FY2023$3.86+31%
FY2022$2.95−5%
FY2021$3.12n/a
FY2020−$4.01−283%
FY2019$2.19−27%
FY2018$3.01+410%
FY2017$0.59−78%
FY2016$2.65+185%
FY2015$0.93−23%
FY2014$1.20−23%
FY2013$1.55+35%
FY2012$1.15−47%
FY2011$2.15+20%

Each fiscal year is the twelve months to its fourth quarter.

Quarter by quarter

QuarterEndedEPSOn a year earlierLast 12 months
Q3 FY26$1.05−3%$4.51
Q2 FY26$1.62+153%$4.54
Q1 FY26$1.31+9%$3.56
Q4 FY25$0.53+1225%$3.45
Q3 FY25$1.08+80%$2.96
Q2 FY25$0.64−23%$2.48
Q1 FY25$1.20n/a$2.67
Q4 FY24$0.04−95%−$4.42
Q3 FY24$0.60−35%−$3.59
Q2 FY24$0.83−16%−$3.26
Q1 FY24−$5.89−650%−$3.10
Q4 FY23$0.87−8%$3.86

Against its peers

Companies in Drug Manufacturers - General nearest Bristol-Myers Squibb's size, closest first, today.

CompanyEPS, 12 monthsGrowth
BMYBristol-Myers Squibb$4.51+52% a year
PFEPfizer$0.76−60% a year
GILDGilead Sciences−$3.16−149% a year
AMGNAmgen$16.09+32% a year
MRKMerck$0.97−87% a year
BIIBBiogen$5.65−46% a year
ABBVAbbVie$5.81+340% a year
JNJJohnson & Johnson$6.60−36% a year
JAZZJazz Pharmaceuticals$14.62
Peer median$5.73

Where Bristol-Myers Squibb ranks

What the EPS figure tells you

Net income divided by diluted shares. The denominator of PE.

One-off charges and gains swing it. The TTM view smooths a single odd quarter.

More on Bristol-Myers Squibb

Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.